Ruti Aga's Six-Year Ban: The Prescription Whose Clinic Did Not Exist

There was a half marathon in China on a March morning, and Ruti Aga won it. The Athletics Integrity Unit's statement, released on Thursday, does not carry a time for that race — no splits, no note on the depth of the field, only the fact that she finished first and that a sample collected afterwards contained methylprednisolone. When a report omits the result, the real result is filed somewhere else. Here it sits inside a six-year ban, a clinic that did not exist, and a prescription nobody had written.

For three decades I have read track and road stories by hunting for the missing number. This time the missing number is not a mark. It is a reason.

Context: the arithmetic of the sanction

Aga is a 32-year-old Ethiopian marathoner. Her name belongs to the generation that won Tokyo in 2026 and finished second at three World Marathon Majors — a 2:18-to-2:20 athlete who raced selectively, picking her way between the Majors and the Asian label circuit.

The AIU counted two separate violations. Presence of a prohibited substance in a sample: two years. Tampering with the investigation: four years. The sum is six, running from 10 September, the same date her provisional suspension began. The 2028 Olympic cycle is closed to her entirely, and a return would come at roughly 38 — an age at which Ethiopian women's marathon depth offers no route back.

According to the statement, she cited a knee injury for which the injection was given. The problem is that the prescription produced was issued under the name of a clinic with no existence; the person who wrote it was a family member with no medical registration; and his explanation was that he had used "an old prescription pad from a former workplace" — a pad the clinic explicitly disowned. Three independent verifications, three failures.

Core: the wrong paper, not the wrong drug

A technical correction matters here, because the whole case turns on it. Methylprednisolone is not an anabolic steroid; it is a glucocorticoid, class S9 on the WADA Prohibited List. And the critical condition of S9 is that it is prohibited in-competition only — by injection, oral or rectal route. An out-of-competition therapeutic injection is entirely lawful. A violation arises only when residues are present in an in-competition sample. In road racing the testing window opens at 23:59 the night before the race, which is why an injection given days earlier still lands in the cup.

That was the legitimate legal doorway, and Aga closed it herself. Genuine treatment, genuine records, a clear explanation of route and timing — with those three, this could have been argued at the no-significant-fault end and reduced sharply. The four-year tampering charge would never have attached. Fabricate a document whose author does not exist, and you destroy your own strongest argument.

The arithmetic speaks too. Two plus four tells us the panel did not treat intent as maximal on the presence charge, but held her fully culpable for the tampering. Whatever mitigation the two-year sanction allowed was eaten by the forgery. And backdating to 10 September is not a concession — time served under provisional suspension is credited, which is procedure, not relief.

One thing should be said plainly, because it is the systemic lesson: this is a story that began with a knee, not a drug. Intra-articular or peri-articular glucocorticoid treatment for knee synovitis is standard sports medicine in high-volume marathoners. The danger is that an injured runner carries pressure to protect appearance-fee income, that glucocorticoids are the cheapest and most available tool for masking pain, and that the medical network around her is informal. An athlete without a credentialed team physician is an athlete who reaches for an old prescription pad. The forged prescription is not the disease; it is the symptom.

Note also where the test happened. China's label-race circuit has long been an attractive, low-risk income tier for East African marathoners between Majors. That same tier is now the AIU's highest-yield testing ground. The appearance-fee economy and the testing economy are colliding inside the same races.

Contrarian: this is a documents case, not a doping case

Headlines that file this under "steroid" will place it in the queue of anabolic cases, and they will be wrong — damagingly wrong, because this substance has no proven endurance benefit. What carried a six-year ban was paper, not pharmacology. The AIU case signals that the enforcement frontier has moved from detection to verification. The question is no longer what was in the sample. It is whether your document survives a phone call.

An uncomfortable argument has to be conceded alongside that. Six years for a substance with no proven endurance gain will look disproportionate, and this case will fuel the charge of heavy-handed enforcement against African road runners. The answer lies not in the length but in its source: the shape of the six was built by Aga's own conduct, not by the AIU.

One confusion should be cleared away. This says nothing about the depth of Ethiopian athletics. The departure of a 32-year-old with no global championship medal changes nothing in Ethiopia's selection calculus. What changes is the risk profile of the entourage around the athlete — the agent, the manager, the "doctor." The statement names only the family member. Whether any agent was investigated is not disclosed, and that gap will be reproduced in the next case.

I still remember the morning of Tokyo 2026 — a quiet, sparing runner on screen who crossed 42 kilometres without letting her face break into a shout. I read it as humility then. I read it now as a habit of keeping things inside.

Takeaway

Where is the person who advised her to manufacture the prescription? How many other prescriptions carry the phone number of the clinic that disowned its own pad? And the question that matters most: how many runners are walking around today with paperwork that would collapse under one verification call? Aga's career is over, but her case is not the answer to that question — it is only the first page.